Xuechun Wang

777 total citations · 1 hit paper
43 papers, 489 citations indexed

About

Xuechun Wang is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Xuechun Wang has authored 43 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Xuechun Wang's work include Pregnancy-related medical research (3 papers), Epigenetics and DNA Methylation (3 papers) and Acute Ischemic Stroke Management (3 papers). Xuechun Wang is often cited by papers focused on Pregnancy-related medical research (3 papers), Epigenetics and DNA Methylation (3 papers) and Acute Ischemic Stroke Management (3 papers). Xuechun Wang collaborates with scholars based in China, United States and Canada. Xuechun Wang's co-authors include Qiaoxiang Dong, Xiangping Chen, Xiaojuan Chen, Chenglian Bai, Jiangfei Chen, Changjiang Huang, Dongren Yang, Yuanhong Chen, Wei Yao and Kaijun Niu and has published in prestigious journals such as New England Journal of Medicine, Blood and Scientific Reports.

In The Last Decade

Xuechun Wang

40 papers receiving 487 citations

Hit Papers

Reteplase versus Alteplase for Acute Ischemic Stroke 2024 2026 2025 2024 10 20 30 40

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuechun Wang China 13 110 87 68 65 56 43 489
Ling Ma China 13 124 1.1× 61 0.7× 97 1.4× 39 0.6× 15 0.3× 24 424
Claire Mackowiak France 9 248 2.3× 81 0.9× 67 1.0× 243 3.7× 39 0.7× 12 701
Wen Lin China 13 162 1.5× 83 1.0× 47 0.7× 54 0.8× 26 0.5× 24 486
Kejia Wu China 14 203 1.8× 30 0.3× 89 1.3× 82 1.3× 25 0.4× 36 559
Jodie Y. Duffy United States 18 172 1.6× 47 0.5× 71 1.0× 57 0.9× 24 0.4× 33 689
Patrycja Kapczuk Poland 11 123 1.1× 49 0.6× 35 0.5× 163 2.5× 121 2.2× 25 563
Hongyu Xue China 13 273 2.5× 35 0.4× 25 0.4× 61 0.9× 95 1.7× 34 618
Xiaolan Li China 13 171 1.6× 51 0.6× 66 1.0× 94 1.4× 37 0.7× 52 505
Clifford Mason United States 14 257 2.3× 54 0.6× 67 1.0× 112 1.7× 107 1.9× 25 693
Nan Bai China 15 296 2.7× 24 0.3× 84 1.2× 143 2.2× 98 1.8× 54 812

Countries citing papers authored by Xuechun Wang

Since Specialization
Citations

This map shows the geographic impact of Xuechun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuechun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuechun Wang more than expected).

Fields of papers citing papers by Xuechun Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuechun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuechun Wang. The network helps show where Xuechun Wang may publish in the future.

Co-authorship network of co-authors of Xuechun Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuechun Wang. A scholar is included among the top collaborators of Xuechun Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuechun Wang. Xuechun Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Yixiao, Xuechun Wang, Wang Zhang, et al.. (2025). In situ tailored confining microenvironment for lung cancer spheroids. Materials Today Bio. 31. 101602–101602. 2 indexed citations
2.
Huang, Yiming, et al.. (2025). COPSOQ III in China: Preliminary Validation of an International Instrument to Measure Psychosocial Work Factors. Healthcare. 13(7). 825–825. 2 indexed citations
3.
Wang, Xuechun, et al.. (2024). AURKA promotes renal cell carcinoma progression via regulation of CCNB1 transcription. Heliyon. 10(8). e27959–e27959. 1 indexed citations
4.
Li, Shuya, Hongqiu Gu, Hao Li, et al.. (2024). Reteplase versus Alteplase for Acute Ischemic Stroke. New England Journal of Medicine. 390(24). 2264–2273. 42 indexed citations breakdown →
5.
Wang, Xuechun, Yuting Meng, Zhijian Dong, et al.. (2024). Segmentation of infarct lesions and prognosis prediction for acute ischemic stroke using non-contrast CT scans. Computer Methods and Programs in Biomedicine. 258. 108488–108488. 3 indexed citations
7.
Qiu, Hongmei, Xuechun Wang, & Yan Shao. (2023). Forward and reverse typing discrepancy and crossmatch incompatibility of ABO blood groups: cause analysis and treatment. Hematology. 28(1). 2240146–2240146. 2 indexed citations
9.
Yan, Xiangyu, Wei Xiao, Xuechun Wang, et al.. (2022). A four-generation family transmission chain of COVID-19 along the China–Myanmar border in October to November 2021. Frontiers in Public Health. 10. 1004817–1004817. 3 indexed citations
10.
Chai, Gaoshang, Jiajun Wu, Yi Liu, et al.. (2022). Sevoflurane inhibits histone acetylation and contributes to cognitive dysfunction by enhancing the expression of ANP32A in aging mice. Behavioural Brain Research. 431. 113949–113949. 15 indexed citations
11.
Wang, Xuechun, et al.. (2022). Lncrna Famlf-2 Inhibits Acute Lymphoblastic Leukemia Apoptosis through the p38 MAPK Signaling Pathway. Blood. 140(Supplement 1). 11515–11516. 1 indexed citations
12.
Gao, Lanlan, Lili Yang, Siyu Zhang, et al.. (2021). Engineering NK-92 Cell by Upregulating CXCR2 and IL-2 Via CRISPR-Cas9 Improves Its Antitumor Effects as Cellular Immunotherapy for Human Colon Cancer. Journal of Interferon & Cytokine Research. 41(12). 450–460. 21 indexed citations
13.
Yan, Jian­ying, et al.. (2020). Safety and feasibility of trial of labor in pregnant women with cesarean scar diverticulum. Journal of International Medical Research. 48(9). 1220754545–1220754545. 4 indexed citations
14.
Wang, Xuechun, et al.. (2020). A Clinical Analysis of the Diagnosis and Treatment of Fetal Sacrococcygeal Teratomas. Cancer Management and Research. Volume 12. 13185–13193. 10 indexed citations
15.
Yan, Jian­ying, et al.. (2020). An analysis of the maternal and infant outcomes in the delayed interval delivery of twins. Taiwanese Journal of Obstetrics and Gynecology. 59(3). 361–365. 3 indexed citations
16.
Peng, Haiyan, et al.. (2019). Clinical application of Catalyst system in cervical cancer radiotherapy. Zhonghua fangshe zhongliuxue zazhi. 28(3). 198–202. 1 indexed citations
17.
Wang, Xuechun, et al.. (2018). Effect of a synthetic inhibitor of urokinase plasminogen activator on the migration and invasion of human cervical cancer cells in vitro. Molecular Medicine Reports. 17(3). 4273–4280. 13 indexed citations
18.
Yao, Wei, et al.. (2015). Elevated Serum Level of Interleukin 17 in a Population With Prehypertension. Journal of Clinical Hypertension. 17(10). 770–774. 40 indexed citations
19.
Yao, Wei, et al.. (2014). High prevalence of metabolic syndrome in a middle-aged and elderly population with prehypertension in Tianjin. Clinical and Experimental Hypertension. 37(5). 369–374. 4 indexed citations
20.
Huang, Changxin, et al.. (2012). Effects of sequential chemotherapy of FOLFIRI/FOLFOX on the endocrine axes of ACTH–cortisol and renin–angiotensin–aldosterone. Journal of Neuro-Oncology. 108(3). 485–490. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026